Quick Takeaways
- Tasso Partners, LLC filed SCHEDULE 13G for PAVmed Inc. Common Stock, Par Value $0.001 Per Share (PAVM).
- Disclosed ownership: 19%.
- Date of event: 21 Feb 2025.
Tasso Partners, LLC - 21 Feb 2025 SCHEDULE 13G Report for PAVmed Inc. Common Stock, Par Value $0.001 Per Share (PAVM)
- Filing Manager
- Tasso Partners, LLC
- Reporting Manager
- Tasso Partners, LLC
- Symbol
- PAVM
- Shares outstanding
- 13,620,899 shares
- Disclosed Ownership
- 2,574,350 shares
- Ownership
- 19%
- Form type
- SCHEDULE 13G
- Filing time
- 28 Feb 2025, 17:29:55 UTC
- Date of event
- 21 Feb 2025
- Next filing
- 03 Apr 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Tasso Partners, LLC disclosed 19% ownership in PAVmed Inc. Common Stock, Par Value $0.001 Per Share (PAVM) on 21 Feb 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 28 Feb 2025, 17:29.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Tasso Partners, LLC | 19% | 2,574,350 | 2,574,350 | 0 | /s/ Dana Carrera | Dana Carrera, Manager of Tasso Capital, LLC, which controls Tasso Partners, LLC | |
| Dana Carrera | 19% | 2,574,350 | 2,574,350 | 0 | /s/ Dana Carrera | Dana Carrera |